• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Manufacturing deals

Recipharm
Manufacturing

CDMO Recipharm to produce malaria vaccine candidates for trials

Swedish CDMO Recipharm and the University of Oxford have expanded their collaboration to include additional manufacturing duties.
Kevin Dunleavy Jun 10, 2025 3:45pm
signing contract

Bio Usawa inks deal to deploy bio manufacturing units in Rwanda

May 27, 2025 9:26am
Photo of a VikingNordic-era ship in the water while the sun sets behind it

Viking taps CordenPharma in $150M obesity drug production deal

Mar 11, 2025 10:25am
Thermo Fisher Scientific headquarters

Lyndra enlists Thermo Fisher for research, manufacturing support

Jan 15, 2025 3:36pm
MA mergers  acquisitions business development BD

Adragos buys out Swiss CDMO Baccinex to boost fill-finish work

Nov 26, 2024 9:20am
Emergent BioSolutions

J&J agrees to pay $50M to settle contract dispute with Emergent

Jul 9, 2024 10:17am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings